My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 111

    1.

    The impact of abnormalities in IGF and inflammatory systems on the metabolic syndrome.

    Kaushal K, Heald AH, Siddals KW, Sandhu MS, Dunger DB, Gibson JM, Wareham NJ.

    Diabetes Care. 2004 Nov;27(11):2682-8.PMID: 15505005 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    C-reactive protein and the insulin-like growth factor (IGF)-system in relation to risk of cardiovascular disease in different ethnic groups.

    Heald AH, Anderson SG, Ivison F, Laing I, Gibson JM, Cruickshank K.

    Atherosclerosis. 2003 Sep;170(1):79-86.PMID: 12957685 [PubMed - indexed for MEDLINE]Related articles

    3.

    Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome.

    Heald AH, Kaushal K, Siddals KW, Rudenski AS, Anderson SG, Gibson JM.

    Exp Clin Endocrinol Diabetes. 2006 Jul;114(7):371-6.PMID: 16915540 [PubMed - indexed for MEDLINE]Related articles

    4.

    Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: a population-based study.

    Undén AL, Elofsson S, Brismar K.

    Clin Endocrinol (Oxf). 2005 Jul;63(1):94-102.PMID: 15963068 [PubMed - indexed for MEDLINE]Related articles

    5.

    Cardiovascular disease in U.S. patients with metabolic syndrome, diabetes, and elevated C-reactive protein.

    Malik S, Wong ND, Franklin S, Pio J, Fairchild C, Chen R.

    Diabetes Care. 2005 Mar;28(3):690-3.PMID: 15735209 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Total insulinlike growth factor 1 and insulinlike growth factor binding protein levels, functional status, and mortality in older adults.

    Kaplan RC, McGinn AP, Pollak MN, Kuller L, Strickler HD, Rohan TE, Xue X, Kritchevsky SB, Newman AB, Psaty BM.

    J Am Geriatr Soc. 2008 Apr;56(4):652-60. Epub 2008 Feb 27.PMID: 18312313 [PubMed - indexed for MEDLINE]Related articles

    7.

    Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.

    Samaras K, Wand H, Law M, Emery S, Cooper D, Carr A.

    Diabetes Care. 2007 Jan;30(1):113-9. Erratum in: Diabetes Care. 2007 Feb;30(2):455. PMID: 17192343 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes.

    Brantsma AH, Bakker SJ, Hillege HL, de Zeeuw D, de Jong PE, Gansevoort RT; PREVEND Study Group.

    Diabetes Care. 2005 Oct;28(10):2525-30.PMID: 16186291 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Association of testosterone, insulin-like growth factor-I, and C-reactive protein with metabolic syndrome in Chinese middle-aged men with a family history of type 2 diabetes.

    Tong PC, Ho CS, Yeung VT, Ng MC, So WY, Ozaki R, Ko GT, Ma RC, Poon E, Chan NN, Lam CW, Chan JC.

    J Clin Endocrinol Metab. 2005 Dec;90(12):6418-23. Epub 2005 Sep 27.PMID: 16189249 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Total serum insulin-like growth factor-1 and C-reactive protein in metabolic syndrome with or without diabetes.

    Efstratiadis G, Tsiaousis G, Athyros VG, Karagianni D, Pavlitou-Tsiontsi A, Giannakou-Darda A, Manes C.

    Angiology. 2006 May-Jun;57(3):303-11.PMID: 16703190 [PubMed - indexed for MEDLINE]Related articles

    11.

    High insulinlike growth factor binding protein 1 level predicts incident congestive heart failure in the elderly.

    Kaplan RC, McGinn AP, Pollak MN, Kuller L, Strickler HD, Rohan TE, Cappola AR, Xue X, Psaty BM.

    Am Heart J. 2008 Jun;155(6):1006-12. Epub 2008 Mar 5.PMID: 18513511 [PubMed - indexed for MEDLINE]Related articles

    12.

    Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin.

    González AS, Guerrero DB, Soto MB, Díaz SP, Martinez-Olmos M, Vidal O.

    Eur J Clin Nutr. 2006 Jun;60(6):802-9. Epub 2006 Feb 22.PMID: 16493453 [PubMed - indexed for MEDLINE]Related articles

    13.

    Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke.

    Kaplan RC, McGinn AP, Pollak MN, Kuller LH, Strickler HD, Rohan TE, Cappola AR, Xue X, Psaty BM.

    J Clin Endocrinol Metab. 2007 Apr;92(4):1319-25. Epub 2007 Jan 30.PMID: 17264182 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Synergy between adiposity, insulin resistance, metabolic risk factors, and inflammation in adolescents.

    Huang RC, Mori TA, Burke V, Newnham J, Stanley FJ, Landau LI, Kendall GE, Oddy WH, Beilin LJ.

    Diabetes Care. 2009 Apr;32(4):695-701. Epub 2009 Jan 8.PMID: 19131468 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men.

    Laaksonen DE, Niskanen L, Nyyssönen K, Punnonen K, Tuomainen TP, Valkonen VP, Salonen R, Salonen JT.

    Diabetologia. 2004 Aug;47(8):1403-10. Epub 2004 Jul 28.PMID: 15309290 [PubMed - indexed for MEDLINE]Related articles

    16.

    Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women.

    Yamaguchi T, Kanatani M, Yamauchi M, Kaji H, Sugishita T, Baylink DJ, Mohan S, Chihara K, Sugimoto T.

    Calcif Tissue Int. 2006 Jan;78(1):18-24. Epub 2006 Jan 6.PMID: 16397738 [PubMed - indexed for MEDLINE]Related articles

    17.

    C-reactive protein level as an independent risk factor of metabolic syndrome in the Korean population. CRP as risk factor of metabolic syndrome.

    Lim S, Lee HK, Kimm KC, Park C, Shin C, Cho NH.

    Diabetes Res Clin Pract. 2005 Nov;70(2):126-33. Epub 2005 Jun 9.PMID: 15950309 [PubMed - indexed for MEDLINE]Related articles

    18.

    Fasting insulin, adiponectin, hs-CRP levels, and the components of metabolic syndrome.

    Adam FM, Nara MG, Adam JM.

    Acta Med Indones. 2006 Oct-Dec;38(4):179-84.PMID: 17132879 [PubMed - indexed for MEDLINE]Related articles

    19.

    Metabolic syndrome and C-reactive protein in the general population: JMS Cohort Study.

    Ishikawa S, Kayaba K, Gotoh T, Nakamura Y, Kajii E.

    Circ J. 2007 Jan;71(1):26-31.PMID: 17186974 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps.

    Schoen RE, Weissfeld JL, Kuller LH, Thaete FL, Evans RW, Hayes RB, Rosen CJ.

    Gastroenterology. 2005 Aug;129(2):464-75.PMID: 16083703 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity